This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Going further and faster to reduce strokes related to atrial fibrillation


ICC, Birmingham

Session led by AHSNs as part of Heart Rhythm Congress which runs 7-10 October.

Includes contribution from Hannah Oatley, Oxford AHSN Clinical Innovation Adoption manager, on developing specialist pharmacists to optimise anti-coagulant therapy.

  • Details of the session here
  • Further information and booking details for the Heart Rhythm Congress here
  • Read more about the Oxford AHSN’s work to reduce stroke related to atrial fibrillation here
Event Types: Clinical Innovation Adoption AHSN Network